Fatigue and Relating Factors in High-Risk Breast Cancer Patients Treated With Adjuvant Standard or High-Dose Chemotherapy: A Longitudinal Study Patients with stage IIB, IIIB, and IVA cervical cancer ...

The odds of cisplatin-induced acute kidney injury decreased with prophylactic administration of intravenous magnesium. Infusing prophylactic magnesium before initiating intravenous cisplatin for ...

Pedmark significantly reduces cisplatin-induced hearing loss in pediatric and AYA patients with non-metastatic solid tumors. The trial confirmed Pedmark's non-interference with cisplatin's antitumor ...

Investigators developed and validated a simple risk score that can predict the risk of severe cisplatin-associated AKI. Investigators have developed and externally validated a prediction model for ...